Title : Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology.

Pub. Date : 2008 Oct

PMID : 18836460






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer"s disease-like pathology. Pyrrolidonecarboxylic Acid amyloid beta (A4) precursor protein Mus musculus
2 Because of their abundance, resistance to proteolysis, rapid aggregation and neurotoxicity, N-terminally truncated and, in particular, pyroglutamate (pE)-modified Abeta peptides have been suggested as being important in the initiation of pathological cascades resulting in the development of Alzheimer"s disease. Pyrrolidonecarboxylic Acid amyloid beta (A4) precursor protein Mus musculus
3 Because of their abundance, resistance to proteolysis, rapid aggregation and neurotoxicity, N-terminally truncated and, in particular, pyroglutamate (pE)-modified Abeta peptides have been suggested as being important in the initiation of pathological cascades resulting in the development of Alzheimer"s disease. Pyrrolidonecarboxylic Acid amyloid beta (A4) precursor protein Mus musculus